Speakers and attendees explored the contours of an industry sector in the throes of regulatory and technological change at the 26th annual Pharmaceutical and Medical Device Ethics and Compliance Congress event in Washington, DC, last week. Discussion unfolded while the federal government was shut down.
Some of the most interesting
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
